Andrew J Sweatt
Overview
Explore the profile of Andrew J Sweatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kholdani C, Lee J, Swenson K, Liu J, Hsi A, Kudelko K, et al.
Pulm Circ
. 2025 Mar;
15(1):e70063.
PMID: 40034146
Benchmarks of clinical management are essential for improving the quality of care. However, the lack of established quality metrics for pulmonary arterial hypertension (PAH) contributes to practice heterogeneity. We assessed...
2.
Kheyfets V, Sweatt A, Zhang H, Nemkov T, Heerdt P, Dzieciatkowska M, et al.
medRxiv
. 2025 Jan;
PMID: 39763543
Background: Pulmonary arterial hypertension (PAH) is a rare but severe and life-threatening condition that primarily affects the pulmonary blood vessels and the right ventricle of the heart. The limited availability...
3.
Sweatt A, Griffiths C, Groves S, Paudel B, Wang L, Kashatus D, et al.
Mol Syst Biol
. 2024 Sep;
20(11):1230-1256.
PMID: 39333715
Protein copy numbers constrain systems-level properties of regulatory networks, but proportional proteomic data remain scarce compared to RNA-seq. We related mRNA to protein statistically using best-available data from quantitative proteomics ...
4.
Tello K, Yogeswaran A, Majeed R, Kiely D, Lawrie A, Brittain E, et al.
Chest
. 2024 Aug;
167(1):224-240.
PMID: 39182575
Background: Patients with COPD frequently demonstrate pulmonary hypertension (PH). Severe PH in patients with COPD, identified by pulmonary vascular resistance (PVR) of > 5 Wood units (WU), is closely linked...
5.
Bagherzadeh S, Celestin B, Santana E, Salerno M, Nadeau K, Sweatt A, et al.
Chest
. 2024 Jul;
166(5):1184-1196.
PMID: 39025204
Background: According to the most recent pulmonary hypertension (PH) guidelines, a main pulmonary artery (MPA) diameter > 25 mm on transthoracic echocardiography supports the diagnosis of PH. However, the size...
6.
Celestin B, Bagherzadeh S, Ichimura K, Santana E, Sanchez P, Tobore T, et al.
Pulm Circ
. 2024 May;
14(2):e12361.
PMID: 38800494
Several indices of right heart remodeling and function have been associated with survival in pulmonary arterial hypertension (PAH). Outcome analysis and physiological relationships between variables may help develop a consistent...
7.
Yogeswaran A, Gall H, Funderich M, Wilkins M, Howard L, Kiely D, et al.
Chest
. 2024 Mar;
166(3):585-603.
PMID: 38508334
Background: Pulmonary hypertension (PH) is a heterogeneous disease with a poor prognosis. Accurate risk stratification is essential for guiding treatment decisions in pulmonary arterial hypertension (PAH). Although various risk models...
8.
Zamanian R, Weatherald J, Sweatt A, Hemnes A, Rashid M, Psotka M, et al.
Am J Respir Crit Care Med
. 2024 Mar;
209(10):1189-1195.
PMID: 38471030
No abstract available.
9.
Sweatt A, Griffiths C, Paudel B, Janes K
bioRxiv
. 2023 Jul;
PMID: 37503057
Protein copy numbers constrain systems-level properties of regulatory networks, but absolute proteomic data remain scarce compared to transcriptomics obtained by RNA sequencing. We addressed this persistent gap by relating mRNA...
10.
Fass O, Regalia K, Sweatt A, Nandwani M, Zikos T, Fernandez-Becker N, et al.
Neurogastroenterol Motil
. 2023 Jun;
35(9):e14635.
PMID: 37357376
Background: Integrated relaxation pressure (IRP) calculation depends on the selection of a single gastric reference sensor. Variable gastric pressure readings due to sensor selection can lead to diagnostic uncertainty. This...